← Back to Search

Dietary Supplement

Beans & Whole Grains for Arterial Stiffness

N/A
Recruiting
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Male, or non-pregnant, non-lactating female, 45 to 65 years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up time points 0 (prior to consumption) and 2 hours post consumption.
Awards & highlights

Study Summary

This trial tests how different foods affect how blood flows through arteries in 10 people; 3 visits to compare black beans, grains & white rice.

Who is the study for?
This trial is for men and non-pregnant, non-lactating women aged 45-65 with arterial stiffness. Participants must not have donated blood recently, be willing to follow the study's rules, and have certain health markers within specific ranges. They can't take vasoactive meds, have high blood pressure or a recent serious infection or medical event.Check my eligibility
What is being tested?
The study tests how black beans, whole grains (wheat berries), or white rice consumed at breakfast affect arterial stiffness in participants. It's a controlled trial where each person tries all three foods across different visits to see which one has better effects on their arteries.See study design
What are the potential side effects?
Since this trial involves common food items rather than medications, side effects are minimal but may include gastrointestinal discomfort or allergic reactions if participants have unknown sensitivities to these foods.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a man or a woman not pregnant or breastfeeding, aged 45-65.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~time points 0 (prior to consumption) and 2 hours post consumption.
This trial's timeline: 3 weeks for screening, Varies for treatment, and time points 0 (prior to consumption) and 2 hours post consumption. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from baseline Augmentation index at 2 hours
Change from baseline Pulse wave velocity at 2 hours
Change from baseline Reflection magnitude at 2 hours
Secondary outcome measures
C-reactive protein
soluble VCAM1

Trial Design

3Treatment groups
Active Control
Placebo Group
Group I: Black Beans (cooked)Active Control1 Intervention
At one of the three visits, participants will consume a ¾ cup of cooked black beans. Participants will be provided with 100 ml of water with the food, and will be allowed to drink water whenever necessary during the 2 hour test period. The participants will not be blinded to the order and the type of food product they receive at a visit, however, the samples will be assigned a number to ensure the analytical team is blinded to the test product until the end of the study. Should the need to re-administer a test product arise, the participant will receive the test product from the same treatment number again at an extra visit after the original 3 visits have been completed.
Group II: Whole Wheat Grain (cooked)Active Control1 Intervention
At one of the three visits, participants will consume a ¾ cup of cooked whole wheat grain. Participants will be provided with 100 ml of water with the food, and will be allowed to drink water whenever necessary during the 2 hour test period. The participants will not be blinded to the order and the type of food product they receive at a visit, however, the samples will be assigned a number to ensure the analytical team is blinded to the test product until the end of the study. Should the need to re-administer a test product arise, the participant will receive the test product from the same treatment number again at an extra visit after the original 3 visits have been completed.
Group III: White Rice (cooked)Placebo Group1 Intervention
At one of the three visits, participants will consume a ¾ cup of cooked white rice. Participants will be provided with 100 ml of water with the food, and will be allowed to drink water whenever necessary during the 2 hour test period. The participants will not be blinded to the order and the type of food product they receive at a visit, however, the samples will be assigned a number to ensure the analytical team is blinded to the test product until the end of the study. Should the need to re-administer a test product arise, the participant will receive the test product from the same treatment number again at an extra visit after the original 3 visits have been completed.

Find a Location

Who is running the clinical trial?

University of ManitobaLead Sponsor
595 Previous Clinical Trials
199,516 Total Patients Enrolled

Media Library

Black Beans (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT05818358 — N/A
Arterial Stiffness Research Study Groups: Black Beans (cooked), Whole Wheat Grain (cooked), White Rice (cooked)
Arterial Stiffness Clinical Trial 2023: Black Beans Highlights & Side Effects. Trial Name: NCT05818358 — N/A
Black Beans (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05818358 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are being recruited to participate in this clinical investigation?

"Confirmative, the clinicaltrial.gov portal details that this scientific experiment is currently recruiting candidates. This research was initially posted on April 1st 2023 and has been recently updated on April 24th 2023. 10 subjects are needed at just one centre of study."

Answered by AI

Is there eligibility criteria to join this medical trial?

"Only 10 participants will be accepted into this trial, who must have arterial stiffness and a chronological age between 45 to 65 years old."

Answered by AI

Are elderly individuals accepted in this research trial?

"According to the terms of engagement, those hoping to be considered for inclusion must fall between a minimum age limit of 45 and maximum age cap of 65."

Answered by AI

Is this research endeavor currently enrolling participants?

"Affirmative, according to clinicaltrials.gov data this trial is still accepting participants. It was initially advertised on April 1st 2023 and the post was most recently updated on April 24th. The total number of required patients stands at 10 with a single medical centre enrolling them all."

Answered by AI
~0 spots leftby Apr 2024